GST on Hospital Medicines: Delhi HC Ruling

The Delhi High Court recently dealt with an important GST controversy affecting the healthcare sector in W.P.(C) No. 19355 of 2025. The dispute revolves around whether medicines, medical consumables, and devices supplied to admitted patients form part of exempt healthcare services or attract separate GST liability.

This case has wider implications for hospitals across India that provide integrated treatment packages to in-patients.

Background of the Dispute

The petitioner, Escorts Heart Institute and Research Centre Ltd., is a multi-specialty hospital providing treatment to in-patients and out-patients. During a GST audit, the department examined the hospital’s billing practices, particularly the manner in which medicines and consumables supplied to admitted patients were invoiced.

On 29 September 2025, the Additional Commissioner, CGST Audit-1 issued a Show Cause Notice (SCN) under Section 76 of the CGST Act, 2017.

Why Section 76 Was Invoked

Section 76 applies when a person:

• Collects any amount as representing GST, and
  
  
• Fails to deposit that amount with the Government.

The department alleged that:

• The hospital charged patients amounts inclusive of GST (embedded in MRP) on medicines and consumables supplied during hospitalization.
  
  
• However, the corresponding GST was allegedly not deposited with the Government.
  
  
• A demand of approximately ₹6.66 crore was proposed.

Aggrieved by this notice, the hospital approached the Delhi High Court through a writ petition.

Core Legal Question

The central issue before the Court is:

When medicines and consumables are supplied to in-patients as part of medical treatment, do they form part of an exempt healthcare service, or are they independent taxable supplies?

Under GST law, healthcare services provided by clinical establishments are generally exempt. However, the taxability of goods supplied during treatment such as drugs, implants, and surgical consumables has been a recurring area of dispute.

The hospital contended that:

• Supplies to in-patients are intrinsically linked to treatment.
  
  
• They are not standalone sales like a retail pharmacy transaction.
  
  
• The supply should be treated as part of a composite healthcare service, which is exempt.

The department, on the other hand, maintained that:

• Goods like medicines remain taxable unless specifically exempt.
  
  
• If GST is collected even indirectly through MRP it must be remitted.
  
  
• Section 76 liability arises regardless of the broader exemption claim.

Proceedings Before the Delhi High Court

The matter was heard by a Division Bench of the Delhi High Court. After considering the submissions, the Court did not immediately quash the show cause notice. Instead, it adopted a balanced approach.

Key Observations & Directions

1. Adjudication to Continue
   The Court permitted the GST authorities to proceed with adjudication of the show cause notice.
   
   
2. Opportunity to Respond
   The hospital was directed to file a detailed reply along with:
   
   
   • Procurement records
     
     
   • Invoices
     
     
   • Billing structures
     
     
   • Tax payment details
     
     
3. Protection from Immediate Recovery
   Importantly, the Court clarified that if a final adjudication order is passed, it shall not be given effect to while the writ petition remains pending.

This ensures that the hospital is protected from coercive recovery while legal questions are still being examined.

Why This Case Matters for the Healthcare Sector

This litigation goes beyond one hospital. It raises broader GST interpretation issues:

1. Composite Supply vs. Independent Supply

Hospitals typically issue consolidated bills covering room rent, nursing, procedures, diagnostics, medicines, and consumables. Determining whether this constitutes a single composite exempt service or multiple taxable supplies is critical.

2. Embedded GST in MRP

Pharmaceutical products attract GST at each stage of supply, with input tax credit available across the supply chain. When hospitals procure such goods and supply them internally to patients, questions arise about whether GST is “collected” again or merely passed through.

3. Section 76 Exposure

Section 76 is stringent. Even if the underlying supply is later held exempt, collection of any amount as tax without depositing it can trigger liability. The final judicial interpretation in this case may clarify the boundaries of this provision.

Practical Implications for Hospitals

Hospitals and healthcare groups should closely review:

• Their inpatient billing models
  
  
• Whether GST components are separately reflected
  
  
• How medicines are procured and accounted for
  
  
• Whether treatment packages clearly reflect composite supply principles

Audit preparedness and proper documentation will be critical in defending similar disputes.

What to Expect Next

The High Court has kept the writ petition pending while allowing adjudication to proceed. The final decision could:

• Clarify whether inpatient medical supplies are automatically covered under healthcare exemption
  
  
• Define the scope of Section 76 in healthcare billing
  
  
• Provide guidance on GST treatment of bundled medical services

A definitive ruling may significantly impact GST compliance practices across the hospital industry.

Conclusion

The case of Escorts Heart Institute and Research Centre Ltd. v. Additional Commissioner, CGST Audit represents a crucial moment in GST jurisprudence relating to healthcare services. While the Delhi High Court has not yet delivered a final verdict on taxability, its interim protection ensures due process.

As the matter progresses, the outcome will likely shape how hospitals structure their billing systems and interpret GST exemptions for in-patient care.